Focus on how investors identify opportunities, prioritize pipeline, and conduct early diligence screening. This would include discussion around technical risk, regulatory pathways, IP, clinical/commercial milestones, founder credibility, and scientific validation. This would also be a good session to prepare investors in asking stronger diligence questions. Will have list of suggested questions and DD tools to distribute.